Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Skin Neoplasms 2Keratosis, Actinic 2Carcinoma, Squamous Cell 2Radiodermatitis 1Breast Neoplasms 1

Interventions

Petrolatum 2Fluorouracil 2trametinib 1talimogene laherparepvec 1sargramostim 1reolysin 1pimonidazole 1pembrolizumab 1fluoromisonidazole 1dabrafenib 1Trimethoprim, Sulfamethoxazole Drug Combination 1Surgical Procedures, Operative 1Sugars 1Radiotherapy 1Radiation 1Povidone-Iodine 1Melphalan 1Granulocyte-Macrophage Colony-Stimulating Factor 1Erlotinib Hydrochloride 1Clindamycin 1Clarithromycin 1Cephalexin 1Azithromycin 1Anti-Bacterial Agents 1Amoxicillin 13-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Skin Neoplasms × Petrolatum × Clear all
NCT04329221 2025-05-07

Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Massachusetts General Hospital

Phase 2 Withdrawn
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms, Keratosis, Actinic

NCT04642287 2025-05-07

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Massachusetts General Hospital

Phase 2 Withdrawn
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡